Companies /Healthcare
Abbott Laboratories
NYSE: ABT Medical Devices
$99.85
▲ $1.36 (+1.38%) today
Markets open · 10:11am ET

Abbott Laboratories (ABT) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+0.98%
Avg. EPS surprise
Consecutive EPS beats
ABT vs Market · 30-day return after each reportABTS&P 500
−6%0%+6%+12%+4.5%+13.2%Q1 25+8.1%+2.4%Q2 25+0.9%+1.0%Q3 25+5.5%−0.2%Q4 25−7.9%+5.3%Q1 26+11.7%+2.9%Q2 26
−6%0%+6%+12%Q1 25Q3 25Q1 26
ABT EPS Trend · estimate vs actualEstimateActual
$0.00$0.50$1.00$1.50$1.07$1.09Q1 25$1.25$1.26Q2 25$1.30$1.30Q3 25$1.49$1.50Q4 25$1.15$1.15Q1 26$1.28$1.31Q2 26
$0.00$0.50$1.00$1.50Q1 25Q3 25Q1 26
ABT Revenue Trend · estimate vs actualEstimateActual
$0$4.0B$8.0B$12.0B$10.4B$10.4BQ1 25$11.0B$11.1BQ2 25$11.4B$11.4BQ3 25$11.8B$11.5BQ4 25$11.0B$11.2BQ1 26$12.5B$12.6BQ2 26
$0$4.0B$8.0B$12.0BQ1 25Q3 25Q1 26

How Often Does Abbott Laboratories Beat Earnings Estimates?

Abbott Laboratories beat EPS estimates in 6 of its last 6 reported quarters, and has beaten 6 quarters in a row.

ABT quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $1.31 est. $1.28 +2.63% $12.6B est. $12.5B +0.62%
Q1 2026 $1.15 est. $1.15 +0.33% $11.2B est. $11.0B +1.51%
Q4 2025 $1.50 est. $1.49 +0.34% $11.5B est. $11.8B −2.91%
Q3 2025 $1.30 est. $1.30 +0.05% $11.4B est. $11.4B −0.21%
Q2 2025 $1.26 est. $1.25 +0.80% $11.1B est. $11.0B +1.08%
Q1 2025 $1.09 est. $1.07 +1.75% $10.4B est. $10.4B −0.57%

Figures from SEC filings and company reports. Not investment advice.